DELTEC ASSET MANAGEMENT LLC - ADAMAS PHARMACEUTICALS INC ownership

ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 66 filers reported holding ADAMAS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 2.80 and the average weighting 0.1%.

Quarter-by-quarter ownership
DELTEC ASSET MANAGEMENT LLC ownership history of ADAMAS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2021$53,000
+10.4%
10,0000.0%0.01%0.0%
Q1 2021$48,000
-95.5%
10,000
-95.9%
0.01%
-95.7%
Q4 2020$1,063,000
-27.5%
245,399
-31.0%
0.16%
-37.8%
Q3 2020$1,466,000
+60.9%
355,8450.0%0.26%
+37.2%
Q2 2020$911,000
-21.5%
355,845
-11.4%
0.19%
-40.5%
Q1 2020$1,161,000
-23.2%
401,845
+0.8%
0.32%
+4.9%
Q4 2019$1,511,000
-48.6%
398,609
-30.7%
0.31%
-58.6%
Q3 2019$2,941,000
-13.9%
574,886
+4.4%
0.74%
-1.2%
Q2 2019$3,415,000
-10.5%
550,836
+2.6%
0.75%
-10.4%
Q1 2019$3,817,000
+89.2%
536,836
+127.4%
0.84%
+49.9%
Q4 2018$2,017,000
-73.4%
236,124
-37.8%
0.56%
-61.9%
Q3 2018$7,596,000
-18.3%
379,424
+5.5%
1.46%
-22.2%
Q2 2018$9,294,000
+76.5%
359,796
+63.3%
1.88%
+78.5%
Q1 2018$5,265,000
+54.9%
220,296
+119.6%
1.05%
+52.0%
Q4 2017$3,399,000100,3000.69%
Other shareholders
ADAMAS PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 984,329$6,999,0004.03%
Broadfin Capital, LLC 2,469,894$17,561,0003.63%
Healthcare Value Capital, LLC 100,000$711,0002.74%
ARMISTICE CAPITAL, LLC 2,744,000$19,510,0001.07%
DELTEC ASSET MANAGEMENT LLC 536,836$3,817,0000.84%
SECTORAL ASSET MANAGEMENT INC 808,924$5,751,0000.69%
Mosaic Family Wealth, LLC 91,314$649,0000.26%
Worth Venture Partners, LLC 59,740$425,0000.24%
EMERALD ADVISERS, LLC 626,247$4,453,0000.18%
EMERALD MUTUAL FUND ADVISERS TRUST 565,319$4,019,0000.16%
View complete list of ADAMAS PHARMACEUTICALS INC shareholders